| AD | Alzheimer’s disease |
| ADA | Adenosine deaminase activity |
| BUN | Blood urea nitrogen |
| BWG% | Body weight gain percent |
| c-Myc | Multifunctional transcription factor |
| CAT | Catalase |
| COX-2 | Cyclooxygenase 2 |
| DAI | Disease activity index |
| EAE | Experimental autoimmune encephalomyelitis |
| ERK1/2 | MAPK3 mitogen-activated protein kinase 3 |
| FAS | Fetal alcohol syndrome |
| FBG | Fasting blood glucose |
| GSH | Glutathione |
| GSSG | Oxidized glutathione |
| HDL | High-density lipoprotein |
| HDL-C | High-density lipoprotein cholesterol |
| HMGCR | 3-Hydroxy-3-methylglutaryl-CoA reductase |
| HO-1 | Heme oxygenase-1 |
| IC50 | Half-maximal inhibitory concentration |
| IL-8 | Interleukin-8 |
| IL-1 α | Interleukin 1-α |
| IL-6 | Interleukin 6 |
| IL-1β | Interleukin 1β |
| IL-10 | Interleukin 10 |
| iNOS | Inducible nitric oxide synthase |
| 5-LOX | 5-Lipooxygenase |
| LDL-C | Low-density lipoprotein cholesterol |
| MAPK | Mitogen-activated protein kinases |
| MDA | Malondialdehyde |
| MPO | Myeloperoxidase |
| mTOR | The mammalian target of rapamycin |
| NADP | Nicotinamide adenine dinucleotide phosphate |
| NAFLD | Nonalcoholic fatty liver disease |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| Nrf2 | Nrf2 transcription factor |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| 8-OHdG | Deoxyguanosine |
| Ox-LDL | Oxidized low-density lipoprotein |
| PCNA | Proliferating cell nuclear antigen |
| PGE2 | Prostaglandin E2 |
| PPAR | Peroxisome proliferator-activated receptor |
| ROS | Reactive oxygen species |
| SOD | Superoxide dismutase |
| SREBP1 | Sterol regulatory element-binding protein 1 |
| T2DM | Type 2 diabetes mellitus |
| TAG | Triacylglycerols |
| TC | Total cholesterol |
| TGF-β | Transforming growth factor β |
| TNFα | Tumor necrosis factor alpha |
| ZO-1 | Zonula occludens-1 protein |